Glucocorticoids (GCs), which bind the GR and allow it to translocate to the nucleus and modulate gene expression, are effective inhibitors of proliferation and tumorigenesis and routinely used in treating T-cell acute lymphoblastic leukemia (T-ALL)[16]. The gene discussed is NR3C1; the disease is T-cell acute lymphoblastic leukemia.